Acquisition by David Tomsche of tradable shares of ImmuCell at 7.7 subject to Rule 16b-3
| ICCC Stock | USD 5.02 0.01 0.20% |
About 51% of ImmuCell's investor base is interested to short. The analysis of the overall investor sentiment regarding ImmuCell suggests that many traders are impartial. The current market sentiment, together with ImmuCell's historical and current headlines, can help investors time the market. In addition, many technical investors use ImmuCell stock news signals to limit their universe of possible portfolio assets.
ImmuCell |
Filed transaction by ImmuCell Director: . Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at news.google.com
 |
ImmuCell Fundamental Analysis
We analyze ImmuCell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ImmuCell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ImmuCell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
ImmuCell is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
ImmuCell Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ImmuCell stock to make a market-neutral strategy. Peer analysis of ImmuCell could also be used in its relative valuation, which is a method of valuing ImmuCell by comparing valuation metrics with similar companies.
Peers
ImmuCell Related Equities
| PTIX | Protagenic Therapeutics | 3.85 | ||||
| TPST | Tempest Therapeutics | 1.16 | ||||
| FENC | Fennec Pharmaceuticals | 0.76 | ||||
| CVKD | Cadrenal Therapeutics, | 0.55 | ||||
| TRGNF | Transgene | 0.00 | ||||
| XOMAO | XOMA | 0.16 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.79 | ||||
| LCTX | Lineage Cell | 2.94 | ||||
| MNOV | MediciNova | 3.83 | ||||
| ONTTF | Oxford Nanopore | 4.00 | ||||
| RZLT | Rezolute | 4.42 | ||||
| LIPO | Lipella Pharmaceuticals | 4.46 | ||||
| HCWB | HCW Biologics | 5.13 |
Complementary Tools for ImmuCell Stock analysis
When running ImmuCell's price analysis, check to measure ImmuCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuCell is operating at the current time. Most of ImmuCell's value examination focuses on studying past and present price action to predict the probability of ImmuCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuCell's price. Additionally, you may evaluate how the addition of ImmuCell to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |